Long-term outcome of cyclosporin rescue therapy in acute, steroid-refractory severe ulcerative colitis

United European Gastroenterology Journal

Volumn 2, Issue 2, 2014, Pages 108-112

  Molnár, Tamás ^a   Farkas, Klaudia ^a   Szepes, Zoltán ^a   Nagy, Ferenc ^a   Szűcs, Mónika ^a   Nyári, Tibor ^a   Bálint, Anita ^a   Wittmann, Tibor ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Colectomy; Cyclosporin; Long term efficacy; Safety; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL;

ADULT; ALOPECIA; ARTICLE; COLON RESECTION; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HUMAN; HYPERTENSION; HYPERTRICHOSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MUSCLE CRAMP; MUSCULOSKELETAL SYSTEM MALFORMATION; MYALGIA; NEPHROTOXICITY; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSORY DYSFUNCTION; SKIN DISEASE; TREATMENT DURATION; TREMOR; ULCERATIVE COLITIS;

EID: 85006192412     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614520865     Document Type: Article

References (13)

1. Hoentjen F, Sakuraba A and Hanauer S. Update on management of ulcerative colitis. Curr Gastroenterol Rep 2011; 13: 475-485.
2. Molnar T, Farkas K, Nyari T, et al. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients. J Gastrointestin Liver Dis 2011; 20: 359-363.
3. Moskovitz DN, Van Assche G, Maenhout et al. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4: 760-765.
4. Rolny P and Vatn M. Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article. Scand J Gastroenterol 2012; 48: 131-135.
5. Loftus CG, Loftus EV and Sandborn WJ. Cyclosporin for refractory ulcerative colitis. Gut 2003; 52: 172-173.
6. Stange EF, Travis SPL, Vermeire S, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2: 1-23.
7. Mocciaro F, Renna S, Orlando A, et al. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study. J Crohns Colitis 2012; 6: 681-686.
8. Sharkey L, Bredin F, Nightingale A, et al. The use of Cyclosporine A in acute steroid-refractory ulcerative colitis: long term outcomes. J Crohns Colitis 2011; 5: 91-94.
9. Kobayashi T, Naganuma M, Okamoto S, et al. Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis. J Gastroenterol 2010; 45: 1129-1137.
10. Cheifetz AS, Stern J, Garud S, et al. Cyclosporine is safe and effective in patients with severe ulcerative colitis. J Clin Gastroenterol 2011; 45: 107-112.
11. Travis SPL, Stange EF, Lemann M, et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 24-62.
12. Sjoberg M, Walch A, Meshkat M, et al. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study. Inflamm Bowel Dis 2012; 18: 212-218.
13. Sternthal MB, Murphy SJ, George J, et al. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008; 103: 937-943.